Answers are grounded in this paper and cite their sources.
Editorial commentary highlights aptamers' potential in diagnostics and therapeutics, suggesting new applications in biotechnology.
As target-specific molecules that can be utilized in both diagnostics and therapeutics, aptamers have gained increasing interest in recent years as alternatives to conventional antibodies. In addition to their low-cost production and lack of batch-to-batch variations due to their synthetic nature, their ease of chemical modification allows them to be readily adapted into various biosensor applications such as fluorescent, electrochemical, and colorimetric platforms. Furthermore, their compatibility with polymeric structures and targeted drug delivery platforms further strengthens their potential in biotechnology.
No takes yet. Share an insight, caveat, or question.
Erkan Mozioğlu (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: